Stock message boards
MNV
Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Notable ETF Inflow Detected - VOO, GE, VZ, PFE
Tuesday, November 11, 10:57 AM ET, by Market News Video Staff

Symbols mentioned in this story: VOO, GE, VZ, PFE Exchange traded funds (ETFs) trade just ...

Notable ETF Inflow Detected - XLV, MRK, GILD, UNH
Tuesday, November 11, 10:57 AM ET, by Market News Video Staff

Symbols mentioned in this story: XLV, MRK, GILD, UNH Exchange traded funds (ETFs) trade just ...

Broker Darlings of the Dow: Merck Ranks As a Top 15 Analyst Pick
Tuesday, November 11, 11:47 AM ET, by Market News Video Staff

A study of analyst recommendations at the major brokerages shows that Merck & Co., Inc ...

JPMorgan Chase Becomes #21 Most Shorted Dow Stock, Replacing Johnson & Johnson
Wednesday, November 12, 9:48 AM ET, by Market News Video Staff

The most recent short interest data has been released by the NASDAQ for the 10/31/2014 ...

Johnson & Johnson Becomes #13 Most Shorted Dow Stock, Replacing MMM
Wednesday, November 12, 9:49 AM ET, by Market News Video Staff

The most recent short interest data has been released by the NASDAQ for the 10/31/2014 ...

  More articles:  1 2 3 4 5 6 7 next »

JNJ Recalls Tylenol Cold Medicine

By Market News Video Staff, Wednesday, November 24, 2:34 PM ET
Play Video: The Importance of ETFs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Johnson & Johnson (NYSE:JNJ) said today it is recalling some of its Tylenol Cold Multi-Symptom products because of the labeling. J&J said the labels did not properly list the alcohol content in the products, and there have been no risks reported from use of the products. The company recalled children’s Benadryl and Motrin earlier in the week.

At 14.42% of the fund, Johnson & Johnson (NYSE:JNJ) is the top holding of the Health Care Select Sector SPDR Fund (AMEX:XLV). Pfizer (NYSE:PFE) is the second-largest holding in the fund at 11.06% of the portfolio, followed by Merck (NYSE:MRK) at 8.91% On the day, XLV is higher by about 0.9% despite the the recall by Johnson & Johnson.


ETF CHANNEL LAUNCHES THE "ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO"

The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors — anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   AMEX   Benadryl   Call   Care   Definition   Definitions   Exchange   Fund   Growth   Johnson   NYSE   Pfizer   SPDR   Sector   Select   Traded   alcohol   allows   asset   children   commodities   content   designed   earlier   flexibility   follow   followed   from   fund   have   holding   labeling   level   list   portfolio   predetermined   products   program   properly   recalled   recalling   regions   reported   said   second   sectors   some   there   today   wherever
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Chart Zero Stock Market Game Stock Market Definitions
MNV

JNJ Recalls Tylenol Cold Medicine | Market News Video | Copyright © 2008 - 2014, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.